Pembrolizumab plus docetaxel used to treat patients with metastatic castration-resistant prostate cancer
Pembrolizumab plus docetaxel used to treat patients with metastatic castration-resistant prostate cancer
INTRAGO: Intraoperative radiotherapy in newly diagnosed glioblastoma
IORT at hospital Del Mar Barcelona in Spain
IORT at University Hospital Augsburg in Germany
Raising awareness of the burden of cervical cancer in the Eastern Mediterranean region
Improving access to palliative care by enhancing primary care services in an upper middle-income country
Genomic profiling of penile squamous cell carcinoma reveals major biomarkers for efficacy of immunotherapy
Comparative cost-effectiveness of alternative imaging and surveillance schedules for testicular seminoma
Nivolumab and salvage nivolumab plus ipilimumab for aRCC
Anti-PSMA antibody radiolabeled with 177Lu improves MFS in high-risk nmCRPC
Erdafitinib demonstrates efficacy in intermediate-risk non–muscle-invasive bladder cancer with FGFR alterations
Cell-free utDNA may predict transurethral resection of bladder tumour pathology in non–muscle invasive bladder cancer